Jessica E Yager1, Daniel F Lozano Beltran2, Faustino Torrico2, Robert H Gilman3, Caryn Bern4. 1. Division of Infectious Diseases, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA. Electronic address: jessica.yager@downstate.edu. 2. Centro Universitario de Medicina Tropical, Facultad de Medicina y CEADES Salud y Medio Ambiente, Universidad Mayor de San Simon, Cochabamba, Bolivia. 3. Asociacion Benefica PRISMA, Lima, Peru; Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA. 4. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Abstract
BACKGROUND: Though the incidence of new Trypanosoma cruzi infections has decreased significantly in endemic regions in the Americas, medical professionals continue to encounter a high burden of resulting Chagas disease among infected adults. The current prevalence of Chagas heart disease in a community setting is not known; nor is it known how recent insecticide vector control measures may have impacted the progression of cardiac disease in an infected population. OBJECTIVES: We sought to determine the current prevalence of T. cruzi infection and associated Chagas heart disease in a Bolivian community endemic for T. cruzi. METHODS: Nested within a community serosurvey in rural and periurban communities in central Bolivia, we performed a cross-sectional cardiac substudy to evaluate adults for historical, clinical, and electrocardiographic evidence of cardiac disease. All adults between the ages of 20 and 60 years old with T. cruzi infection and those with a clinical history, physical exam, or electrocardiogram consistent with cardiac abnormalities were also scheduled for echocardiography. RESULTS: Of the 604 cardiac substudy participants with definitive serology results, 183 were seropositive for infection with T. cruzi (30.3%). Participants who were seropositive for T. cruzi infection were more likely to have conduction system defects (1.6% vs. 0% for complete right bundle branch block and 10.4% vs. 1.9% for any bundle branch block; p = 0.008 and p < 0.001, respectively). However, there was no statistically significant difference in the prevalence of bradycardia among seropositive versus seronegative participants. Echocardiogram findings were not consistent with a high burden of Chagas cardiomyopathy: valvulopathies were the most common abnormality, and few participants were found to have low ejection fraction or left ventricular dilatation. No participants had significant heart failure. CONCLUSIONS: Though almost one-third of adults in the community were seropositive for T. cruzi infection, few had evidence of Chagas heart disease.
BACKGROUND: Though the incidence of new Trypanosoma cruzi infections has decreased significantly in endemic regions in the Americas, medical professionals continue to encounter a high burden of resulting Chagas disease among infected adults. The current prevalence of Chagas heart disease in a community setting is not known; nor is it known how recent insecticide vector control measures may have impacted the progression of cardiac disease in an infected population. OBJECTIVES: We sought to determine the current prevalence of T. cruzi infection and associated Chagas heart disease in a Bolivian community endemic for T. cruzi. METHODS: Nested within a community serosurvey in rural and periurban communities in central Bolivia, we performed a cross-sectional cardiac substudy to evaluate adults for historical, clinical, and electrocardiographic evidence of cardiac disease. All adults between the ages of 20 and 60 years old with T. cruzi infection and those with a clinical history, physical exam, or electrocardiogram consistent with cardiac abnormalities were also scheduled for echocardiography. RESULTS: Of the 604 cardiac substudy participants with definitive serology results, 183 were seropositive for infection with T. cruzi (30.3%). Participants who were seropositive for T. cruzi infection were more likely to have conduction system defects (1.6% vs. 0% for complete right bundle branch block and 10.4% vs. 1.9% for any bundle branch block; p = 0.008 and p < 0.001, respectively). However, there was no statistically significant difference in the prevalence of bradycardia among seropositive versus seronegative participants. Echocardiogram findings were not consistent with a high burden of Chagas cardiomyopathy: valvulopathies were the most common abnormality, and few participants were found to have low ejection fraction or left ventricular dilatation. No participants had significant heart failure. CONCLUSIONS: Though almost one-third of adults in the community were seropositive for T. cruzi infection, few had evidence of Chagas heart disease.
Authors: Maria Carmo P Nunes; Marcia M Barbosa; Antônio Luiz P Ribeiro; Enrico A Colosimo; Manoel O C Rocha Journal: J Am Soc Echocardiogr Date: 2009-01 Impact factor: 5.251
Authors: J H Maguire; K E Mott; J S Lehman; R Hoff; T M Muniz; A C Guimarães; I Sherlock; R H Morrow Journal: Am Heart J Date: 1983-02 Impact factor: 4.749
Authors: Cristina Alonso-Vega; Julio A Urbina; Sergi Sanz; María-Jesús Pinazo; Jimy José Pinto; Virginia R Gonzalez; Gimena Rojas; Lourdes Ortiz; Wilson Garcia; Daniel Lozano; Dolors Soy; Rosa A Maldonado; Rana Nagarkatti; Alain Debrabant; Alejandro Schijman; M Carmen Thomas; Manuel Carlos López; Katja Michael; Isabela Ribeiro; Joaquim Gascon; Faustino Torrico; Igor C Almeida Journal: BMJ Open Date: 2021-12-31 Impact factor: 2.692
Authors: Lyda Z Rojas; Marija Glisic; Laura Pletsch-Borba; Luis E Echeverría; Wichor M Bramer; Arjola Bano; Najada Stringa; Asija Zaciragic; Bledar Kraja; Eralda Asllanaj; Rajiv Chowdhury; Carlos A Morillo; Oscar L Rueda-Ochoa; Oscar H Franco; Taulant Muka Journal: PLoS Negl Trop Dis Date: 2018-06-13